1. Periodic limb movements while awake (PLMA) as a manifestation of wearing-off in Parkinson’s disease: a case series and review of the literature;Alshimemeri;Mov. Disord. Clin. Pract.,2022
2. Association of regional atrophy with naming decline in primary progressive aphasia;Breining;Neurology,2022
3. Hypothalamic functional connectivity and apathy in people with alzheimer’s disease and cognitively normal healthy controls;Chaudhary;J. Alzheimers Dis.,2022
4. Clinical Review Report: Apomorphine (Movapo): (Paladin Labs Inc.): Indication: The acute, intermittent treatment of hypomobility “off” episodes (“end-of-dose wearing off” and unpredictable “on/off” episodes) in patients with advanced Parkinson’s disease [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Feb. PMID: 30475549.
5. Opicapone: once-daily COMT inhibitor for the treatment of wearing off in Parkinson’s disease;Craft;Sr Care Pharm.,2022